Dámaso Alejandro Pardo
Patentnews.-el ex-presidente del Instituto Nacional de la Propiedad Industrial de la Argentina, Dámaso Alejandro Pardo, está siendo investigado por sus conexiones con la oficina de marcas y patentes del gobierno de los Estados Unidos (USPTO) y por favorecer a sus empresas.
Fuentes consultadas aseguran que el comportamiento de Pardo en relación a la USPTO implica la anexión del INPI a los estándares de marcas y patentes de la oficina de Estados Unidos y que este hecho constituye una anomália en materia de propiedad industrial, que se asemeja a un accionar asociado a comportamientos de empleado a sueldo de los EEUU.
Todo comenzó cuando el Instituto Nacional de la Propiedad Industrial publicó
en el Boletín oficial del día 5 de diciembre de 2016 la Resolución 125/2016 firmada por el
presidente del instituto, Dámaso Pardo, que modificaba la realización de
exámen de fondo de las solicitudes de patentes extranjeras que ingresaran
en la oficina de patentes (procedimiento que en la actualidad se realiza en la práctica de los examinadores de patentes del INPI).
Pardo, ex socio de José Alfredo Martínez de Hoz
(h) en el estudio PAGBAM hasta días antes de asumir su cargo en el INPI,
intentaba responder a los airados reclamos realizados por CILFA al
ministro de producción de entonces, Francisco Cabrera.
Las farmacéuticas nacionales sospechan que estas resoluciones firmadas por Dámaso Pardo para convalidar el memorandum de entendimiento con la USPTO ocultaron
maniobras que podrían realizarse dentro de la Administración Nacional de
Patentes para intentar conceder
patentes farmacéuticas de interés estratégico para empresas como Gilead, Novarties, Pfizer, Astrazéneca y
biotecnológicas como Monsanto-Bayer o Syngenta.
Fuentes de CILFA aseguran que los examinadores replican los informes que
provienen de las oficinas de Europa o EEUU para responder a las
exigencias de producción de expedientes a las que son sometidos los
profesionales de la oficina de patentes con el objetivo de reducir retrasos en los
tiempos de concesión, exigidos por las empresas estadounidenses
agrupadas en CAEME y AmCham.
Las empreas farmacéuticas estadounidenses agrupadas en CAEME y los abogados de la asociación argentina de agentes de la propiedad industrial (AAAPI) son querellantes en la causa judicial iniciada para derogar la Resolución conjunta que establece las Directrices de patentamiento de propductos farmacéuticos y biotecnológicos que aplica la Aministración Nacional de Patentes.
Más irregularidades investigadas
Las empreas farmacéuticas estadounidenses agrupadas en CAEME y los abogados de la asociación argentina de agentes de la propiedad industrial (AAAPI) son querellantes en la causa judicial iniciada para derogar la Resolución conjunta que establece las Directrices de patentamiento de propductos farmacéuticos y biotecnológicos que aplica la Aministración Nacional de Patentes.
Más irregularidades investigadas
Recientemente, se ha iniciado una investigación para determinar si
solicitudes fueron alteradas ilegalmente (antes de entrada en vigencia la Resolución INPI N° P -56) -tanto en los expedientes físicos como en el sistema de patentes del organismo- para favorecer el
otorgamiento de títulos de patentes que estaban anteriormente desitidas, pero que
a la llegada de Dámaso Pardo al INPI y por medio de maniobras fraudulentas habrían sido reingresados al circuito
administrativo para su concesión, hecho que motivara el desplazamiento
de empleados del archívo de patentes aunque se sospecha del involucramiento de un alto funcionario del INPI a cargo de la administración del Instituto.
En aquel entonces, diputados del Frente para la Victoria
presentaron un duro proyecto de resolución en el que cuestionaron la
medida y exigieron que el INPI, que depende del Ministerio de la
Producción, brinde "información precisa y detallada" sobre la gestión
del organismo, sobre su titular y empresas a las que representaba como
abogado antes de acceder a su cargo, y respecto de la resolución 56.
Los diputados también cuestionaron al titular del organismo, Dámaso Pardo, al argumentar que, según la revista "Chambers and Partners Latin American", el estudio
Pérez Alati, Grondona, Benítez Artnsen y Martínez de Hoz "cuenta entre sus clientes con
importantes compañías multinacionales con fuertes intereses vinculados a
las patentes de invención".
En ese sentido, mencionaron que entre los clientes del polémico estudio
de abogados PAGBAM, que integraba Pardo se encuentran empresas con intereses en
el sector, como "Dow Chemical, Exxon Mobil, Shell, Hewlett-Packard,
Google, Youtube, Spotify, Netflix", entre otras. Ahora Martinez de Hoz(h) inició su nuevo estudio de abogados MHR orientado a los negocios del yacimiento "Vaca Muerta".
El pedido de información del FpV llevó las firmas de los diputados
Eduardo "Wado" de Pedro, Axel Kicillof, Lautaro Gervasoni, Martín Pérez,
Abel Furlán, Mauricio Gómez Bull, Luis Bardeggia, Analuz Carol, Liliana
Mazure y Matías Rodríguez.
Dámaso Pardo fue además un intenso lobista para impulsar el tratado de cooperación en materia de patentes (PCT) que se encuentra en revisión legal en la Cámara de Diputados de Argentina y es exigida por las grandes empresas extranjeras y el saliente gobierno de Macri.
El presidente del INPI durante el gobierno de Mauricio Macri redujo la concesión de patentes nacionales un 40% aunque mantuvo la cantidad de concesión de patentes extranjeras. Asimismo logró que el canciller argentino, Jorge Faurie, lo postule como candidato por Argentina a las elecciones a director general de la OMPI a llevarse a cabo en marzo del 2020 en Ginebra.
Argentina: Investigation of the connection between the former INPI president and the United States government office
Patentnews.-the former president of the National Institute of Industrial Property of Argentina, Dámaso Alejandro Pardo, is being investigated for his connections with the trademark and patent office of the United States government (USPTO) and for favoring his companies.
Sources consulted ensure that Pardo's behavior in relation to the USPTO implies the annexation of the INPI to the standards of trademarks and patents of the United States office and that this fact constitutes an anomaly regarding industrial property, which resembles an action associated with paid employee behavior in the US.
It all started when the National Institute of Industrial Property published in the Official Gazette of December 5, 2016, Resolution 125/2016 signed by the president of the institute, Dámaso Pardo, which modified the realization of substantive examination of patent applications foreigners entering the patent office (a procedure that is currently performed in the practice of INPI patent examiners).
Pardo, a former partner of José Alfredo Martínez de Hoz (h) in the PAGBAM study until days before assuming his position at the INPI, was trying to respond to the angry claims made by CILFA to the then production minister, Francisco Cabrera.
National pharmacists suspect that these resolutions signed by Dámaso Pardo to validate the memorandum of understanding with the USPTO concealed maneuvers that could be carried out within the National Patent Administration to try to grant pharmaceutical patents of strategic interest to companies such as Gilead, Novarties, Pfizer, Astrazéneca and biotechnology such as Monsanto-Bayer or Syngenta.
CILFA sources assure that the examiners replicate the reports that come from the offices of Europe or the US to respond to the demands of production of files to which the professionals of the patent office are submitted in order to reduce delays in the times of concession, demanded by the US companies grouped in CAEME and AmCham.
The US pharmaceutical companies grouped in CAEME and the lawyers of the Argentine Association of Industrial Property Agents (AAAPI) are complainants in the legal case initiated to repeal the Joint Resolution that establishes the Patents Guidelines for pharmaceutical and biotechnological products applied by the Administration National Patent.
More irregularities investigated
Recently, an investigation has been initiated to determine if applications were illegally altered (before INPI Resolution No. P -56) - both in the physical files and in the body's patent system - to favor the granting of titles of patents that were previously desitted, but that upon the arrival of Dámaso Pardo to the INPI and through fraudulent maneuvers they would have been re-entered into the administrative circuit for granting, a fact that motivated the displacement of employees from the patent archives even though the involvement of a senior INPI official in charge of the administration of the Institute.
At that time, deputies of the Front for Victory presented a tough draft resolution in which they questioned the measure and demanded that the INPI, which depends on the Ministry of Production, provide "accurate and detailed information" on the management of the agency, on its owner and companies he represented as a lawyer before accessing his position, and regarding resolution 56.
The deputies also questioned the head of the organization, Dámaso Pardo, when arguing that, according to the magazine "Chambers and Partners Latin American", the study Pérez Alati, Grondona, Benítez Artnsen and Martínez de Hoz "counts among its clients with important multinational companies with strong interests linked to invention patents. "
In that sense, they mentioned that among the clients of the controversial PAGBAM law firm, which was part of Pardo, are companies with interests in the sector, such as "Dow Chemical, Exxon Mobil, Shell, Hewlett-Packard, Google, YouTube, Spotify, Netflix" , among other. Now Martinez de Hoz (h) started his new MHR law firm oriented to the business of the "Vaca Muerta" field.
The request for information from the FpV was signed by Pedro Eduardo "Wado", Pedro Axel Kicillof, Lautaro Gervasoni, Martín Pérez, Abel Furlán, Mauricio Gómez Bull, Luis Bardeggia, Analuz Carol, Liliana Mazure and Matías Rodríguez.
Dámaso Pardo was also an intense lobbyist to promote the patent cooperation treaty (PCT) that is under legal review in the Chamber of Deputies of Argentina and is demanded by large foreign companies and the outgoing Macri government.
The president of the INPI during the government of Mauricio Macri reduced the granting of national patents by 40% although he maintained the amount of granting of foreign patents. He also managed to have Argentine Foreign Minister Jorge Faurie nominate him as a candidate for Argentina to the WIPO Director General elections to be held in March 2020 in Geneva.
Dámaso Pardo fue además un intenso lobista para impulsar el tratado de cooperación en materia de patentes (PCT) que se encuentra en revisión legal en la Cámara de Diputados de Argentina y es exigida por las grandes empresas extranjeras y el saliente gobierno de Macri.
El presidente del INPI durante el gobierno de Mauricio Macri redujo la concesión de patentes nacionales un 40% aunque mantuvo la cantidad de concesión de patentes extranjeras. Asimismo logró que el canciller argentino, Jorge Faurie, lo postule como candidato por Argentina a las elecciones a director general de la OMPI a llevarse a cabo en marzo del 2020 en Ginebra.
Argentina: Investigation of the connection between the former INPI president and the United States government office
Patentnews.-the former president of the National Institute of Industrial Property of Argentina, Dámaso Alejandro Pardo, is being investigated for his connections with the trademark and patent office of the United States government (USPTO) and for favoring his companies.
Sources consulted ensure that Pardo's behavior in relation to the USPTO implies the annexation of the INPI to the standards of trademarks and patents of the United States office and that this fact constitutes an anomaly regarding industrial property, which resembles an action associated with paid employee behavior in the US.
It all started when the National Institute of Industrial Property published in the Official Gazette of December 5, 2016, Resolution 125/2016 signed by the president of the institute, Dámaso Pardo, which modified the realization of substantive examination of patent applications foreigners entering the patent office (a procedure that is currently performed in the practice of INPI patent examiners).
Pardo, a former partner of José Alfredo Martínez de Hoz (h) in the PAGBAM study until days before assuming his position at the INPI, was trying to respond to the angry claims made by CILFA to the then production minister, Francisco Cabrera.
National pharmacists suspect that these resolutions signed by Dámaso Pardo to validate the memorandum of understanding with the USPTO concealed maneuvers that could be carried out within the National Patent Administration to try to grant pharmaceutical patents of strategic interest to companies such as Gilead, Novarties, Pfizer, Astrazéneca and biotechnology such as Monsanto-Bayer or Syngenta.
CILFA sources assure that the examiners replicate the reports that come from the offices of Europe or the US to respond to the demands of production of files to which the professionals of the patent office are submitted in order to reduce delays in the times of concession, demanded by the US companies grouped in CAEME and AmCham.
The US pharmaceutical companies grouped in CAEME and the lawyers of the Argentine Association of Industrial Property Agents (AAAPI) are complainants in the legal case initiated to repeal the Joint Resolution that establishes the Patents Guidelines for pharmaceutical and biotechnological products applied by the Administration National Patent.
More irregularities investigated
Recently, an investigation has been initiated to determine if applications were illegally altered (before INPI Resolution No. P -56) - both in the physical files and in the body's patent system - to favor the granting of titles of patents that were previously desitted, but that upon the arrival of Dámaso Pardo to the INPI and through fraudulent maneuvers they would have been re-entered into the administrative circuit for granting, a fact that motivated the displacement of employees from the patent archives even though the involvement of a senior INPI official in charge of the administration of the Institute.
At that time, deputies of the Front for Victory presented a tough draft resolution in which they questioned the measure and demanded that the INPI, which depends on the Ministry of Production, provide "accurate and detailed information" on the management of the agency, on its owner and companies he represented as a lawyer before accessing his position, and regarding resolution 56.
The deputies also questioned the head of the organization, Dámaso Pardo, when arguing that, according to the magazine "Chambers and Partners Latin American", the study Pérez Alati, Grondona, Benítez Artnsen and Martínez de Hoz "counts among its clients with important multinational companies with strong interests linked to invention patents. "
In that sense, they mentioned that among the clients of the controversial PAGBAM law firm, which was part of Pardo, are companies with interests in the sector, such as "Dow Chemical, Exxon Mobil, Shell, Hewlett-Packard, Google, YouTube, Spotify, Netflix" , among other. Now Martinez de Hoz (h) started his new MHR law firm oriented to the business of the "Vaca Muerta" field.
The request for information from the FpV was signed by Pedro Eduardo "Wado", Pedro Axel Kicillof, Lautaro Gervasoni, Martín Pérez, Abel Furlán, Mauricio Gómez Bull, Luis Bardeggia, Analuz Carol, Liliana Mazure and Matías Rodríguez.
Dámaso Pardo was also an intense lobbyist to promote the patent cooperation treaty (PCT) that is under legal review in the Chamber of Deputies of Argentina and is demanded by large foreign companies and the outgoing Macri government.
The president of the INPI during the government of Mauricio Macri reduced the granting of national patents by 40% although he maintained the amount of granting of foreign patents. He also managed to have Argentine Foreign Minister Jorge Faurie nominate him as a candidate for Argentina to the WIPO Director General elections to be held in March 2020 in Geneva.
